S. 3175 · 109th Congress
Life-Saving Medicines Export Act of 2006
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
LeahySponsorNo cosponsors.
Life-Saving Medicines Export Act of 2006 - Allows the Director of the U.S. Patent and Trademark Office (USPTO) to issue a compulsory license to a generic manufacturer of a pharmaceutical product or a patented product needed to prevent or treat potentially life threatening public health problems for the purposes of manufacturing and exporting such…
What it does: CRS summary · Introduced in Senate · May 25, 2006
Life-Saving Medicines Export Act of 2006 - Allows the Director of the U.S. Patent and Trademark Office (USPTO) to issue a compulsory license to a generic manufacturer of a pharmaceutical product or a patented product needed to prevent or treat potentially life threatening public health problems for the purposes of manufacturing and exporting such pharmaceutical products to an eligible country. Allows exportation to a country that is a least developed country as designated by the United Nations (U.N.) or a country that lacks sufficient manufacturing capacities to produce the pharmaceutical product. Sets forth application requirements for compulsory licenses, including that the manufacturer sought a voluntary license from the patent holder.
Requires the Director to establish an office within USPTO to assist applicants and eligible counties, nongovernmental organizations, or nations likely to become eligible countries in identifying companies in the United States which could provide pharmaceutical products under this Act.
Sets forth formulas for calculating the royalty amount that the holder of a compulsory license must pay to the patent holder.
Allows the Director to grant a compulsory license to a generic manufacturer on an expedited basis for a limited period for a pharmaceutical product to address a national emergency or other circumstances of extreme urgency.
Declares that it is not patent infringement to manufacture and export a pharmaceutical product in accordance with this Act.
Requires the Director to establish the National Advisory Board on Implementation of the General Council Decision to provide advice and guidance regarding the implementation and administration of the compulsory licensing program established under this Act.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Life-Saving Medicines Export Act of 2006
Latest action (May 25, 2006): Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S5247-5252)
Policy area: Commerce · Origin: Senate · Introduced: May 25, 2006
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.